Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;23(3):301-310.
doi: 10.1177/1099800420959721. Epub 2020 Sep 22.

A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival

Daniel C McFarland  1 , Andrew H Miller  2 , Christian Nelson  1
Affiliations

A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival

Daniel C McFarland et al. Biol Res Nurs. 2021 Jul.

Abstract

Background: Depression and inflammation are concomitantly elevated in patients with lung cancer and may have collective survival implications. However, the longitudinal relationship between depression and inflammation in patients with metastatic lung cancer is not fully appreciated. We hypothesized that longitudinal changes in inflammation and depression would be concordant; that longitudinally elevated inflammation would lead to greater depression over time; and that depression with inflammation would be more persistent than depression without inflammation.

Methods: Patients with metastatic lung cancer (n = 68) were assessed for clinically significant depression (Hospital Anxiety and Depression Scale ≥ 8) and inflammation (C-Reactive Protein ≥ 1 mg/L) along with demographic variables. Survival estimations were made using Cox Proportional Hazard Model and Kaplan-Meier plot analyses.

Results: At baseline (T1), 15% had depression and 35% had increased inflammation followed by 18% with depression and 38% with increased inflammation 4.7 months later (T2). The odds ratio of depression in the presence of clinically significant inflammation was 4.8 at T1 and 5.3 at T2. Between time points, inflammation difference correlated with depression difference (r = -.26, p = .03). Significant depression at both time points was associated with a 4 fold risk of inferior survival while significant inflammation at any time point was associated with >3 fold risk of inferior survival.

Conclusions: Depression and inflammation track together over time and have variable implications on survival. Persistent depression is particularly detrimental but incidental inflammation is more sensitive to predicting poor survival. These findings have implications for treating depression early in the lung cancer trajectory.

Keywords: C-reactive protein; depression; inflammation; longitudinal; lung cancer; prognosis; survival.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
TOP: Kaplan-Meier plot survival estimations of patients with no inflammation at any time point, 1) clinically significant inflammation (CRP ≥ 1 mg/L) at any time point, and 2) clinically significant inflammation at both time points. BOTTOM: Kaplan-Meier plot survival estimations of patients with no depression at any time point, 1) clinically significant depression (HADS-D ≥ 8) at any time point, and 2) clinically significant depression at both time points.
See this image and copyright information in PMC

References

    1. Akin S., Can G., Aydiner A., Ozdilli K., Durna Z. (2010). Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. European Journal of Oncology Nursing, 14(5), 400–409. 10.1016/j.ejon.2010.01.003 - DOI - PubMed
    1. Araujo A. S., Nogueira I. C., Gomes Neto A., de Medeiros I. L., Morano M. T., da Silva G. P., Santos F. A., De Moraes Filho M. O., Pereira E. D. (2016). The impact of lung cancer resection surgery on fibrinogen and C-reactive protein and their relationship with patients outcomes: A prospective follow up study. Cancer Biomarkers, 16(1), 47–53. 10.3233/CBM-150539 - DOI - PubMed
    1. Arrieta O., Angulo L. P., Nunez-Valencia C., Dorantes-Gallareta Y., Macedo E. O., Martinez-Lopez D., Alvarado S., Corona-Cruz J. F., Onate-Ocana L. F. (2013). Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology, 20(6), 1941–1948. 10.1245/s10434-012-2793-5 - DOI - PubMed
    1. Bjelland I., Dahl A. A., Haug T. T., Neckelmann D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77. - PubMed
    1. Braun D. P., Gupta D., Staren E. D. (2011). Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer, 11, 353. 10.1186/1471-2407-11-353 - DOI - PMC - PubMed

Publication types